Yahoo•2026-04-22
STERIS' Q4 2026 Earnings: What to ExpectSTE — STERIS plc
NYSE · Health Care · Health Care
$221.80-12.70%Market cap21.91B
- Latest Close
- $221.8
- 30-Day Move
- -12.7%
- Market Cap
- $21.9B
- Shares Outstanding
- 98,080,000
- P/E Ratio
- 30.95
- P/B Ratio
- 3.37
NYSE:STEHealth Care / Health CareDelayed public snapshot
STERIS plc
A read-only Alphactor snapshot forSTERIS plc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-24
Topline snapshot
Latest Close
$221.8
30-Day Move
-12.7%
Market Cap
$21.9B
Shares Outstanding
98,080,000
P/E Ratio
30.95
P/B Ratio
3.37
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$221.80
-12.7%last 90 delayed daily bars
Market cap$21.9B
90D High
$269.44
90D Low
$209.97
Avg Volume
753,374
What stands out
Gross margin is running at 44.1%, which gives a quick read on operating quality before you open the full model.
Net margin is 12.1%, useful for comparing STE against peers in Health Care.
STE is down 12.7% over the last 30 trading days shown on this page.
Latest operating income is $274M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$156.14
Rule of 40
20.5%
Fundamentals snapshot
Latest Close
$221.8
30-Day Move
-12.7%
Market Cap
$21.9B
Shares Outstanding
98,080,000
P/E Ratio
30.95
P/B Ratio
3.37
ROE
9.3%
ROA
6.1%
Gross Margin
44.1%
Operating Margin
17.0%
Net Margin
12.1%
Debt / Equity
0.31
Current Ratio
1.96
Dividend Yield
1.1%
Latest Revenue
$1.5B
Financial statement snapshot
Revenue
$1.5B
Gross Profit
$656M
Operating Income
$274M
Net Income
$193M
Gross Margin
4411.0%
Net Margin
1214.0%
Current Ratio
1.96
Debt / Equity
0.31
Valuation snapshot
Fair Value
$156.14
Upside / Downside
-29.6%
Signal
Overvalued
Implied Growth
10.6%
DCF
$148.87
EPV
$61.93
EV/Rev
$257.61
Growth Assumption
8.9%
Discount Rate
8.4%
Terminal Growth
2.0%
Base FCF
$778M
Valuation spread
Current Price
$221.80
Composite Fair Value
$156.14
DCF
$148.87
EPV
$61.93
EV/Rev
$257.61
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Moderate growth priced in
Quality snapshot
Altman Z
5.03
Safe
Piotroski
8
Strong (7-9)
Cash Conversion
1.87x
Rule of 40
20.5%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $4.2B | $478M | $244M | $397M |
| 2023-12-31 | $4.5B | $792M | $107M | $395M |
| 2024-12-31 | $5.1B | $862M | $378M | $613M |
| 2025-12-31 | $5.5B | $961M | $615M | $778M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Yahoo•2026-04-21
STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026Yahoo•2026-04-20
Surgical Equipment & Consumables - Diversified Stocks Q4 Earnings: STERIS (NYSE:STE) Firing on All CylindersAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Institutional holders snapshot
Qube Research & Technologies
Filed 2025-05-15
--
--
Two Sigma Advisers
Filed 2025-11-14
--
--
Vanguard Group
Filed 2026-01-29
$3.1B
+0.6%
BlackRock
Filed 2024-05-10
$2.2B
--
Geode Capital Management
Filed 2026-02-09
$637M
+0.6%
Invesco
Filed 2026-02-19
$358M
+10.2%
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.